ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

DICE DICE Therapeutics Inc

47.55
0.00 (0.00%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
DICE Therapeutics Inc DICE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 47.55 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
47.55 47.55
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/8/202307:00EDGAR2Form 15-12G - Securities registration termination [Section..
10/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
09/8/202315:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202315:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202308:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
09/8/202308:38EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
09/8/202308:32EDGAR2Form POS AM - Post-Effective amendments for registration..
09/8/202308:26EDGAR2Form 8-K - Current report
09/8/202308:20EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
09/8/202308:02PRNUSLilly Completes Acquisition of DICE Therapeutics
08/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/7/202306:11EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
25/7/202305:55PRNUSLilly Announces Extension of Tender Offer to Acquire DICE
17/7/202316:23EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30/6/202315:22EDGAR2Form SC 14D9 - Solicitation, recommendation statements
20/6/202309:15DJNTrending: Eli Lilly Buys DICE Therapeutics in Deal Worth..
20/6/202306:42DJNEli Lilly to Acquire DICE Therapeutics for $2.4 Billion
20/6/202305:45PRNUSLilly to Acquire DICE Therapeutics to Advance Innovation in..
13/6/202315:05GLOBEDICE Therapeutics to Host R&D Investor Event on Tuesday,..
11/5/202315:05GLOBEDICE Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock